Hypertension · 2017 · 49 citations · 24 references
Public HealthMaternal HealthObstetricsHigh-risk PregnancyMaternal-fetal MedicinePrenatal DiagnosisEclampsiaFetal OutcomesGestational Age AssessmentPerinatal Risk FactorsPregnancyPrenatal Risk AssessmentBiochemical Marker PredictionBiomarker Cutoff ValuesBiomarkers Of PreeclampsiaGestational Age MeasurementIncremental Diagnostic ValuePreeclampsia PathophysiologyPreeclampsia Risk AssessmentPreeclampsia Risk Prediction
To assess the incremental value of a single determination of the serum levels of sFlt-1 (soluble Fms-like tyrosine kinase 1) and PlGF (placental growth factor) or their ratio, without using cutoff values, for the prediction of maternal and fetal/neonatal complications and pregnancy prolongation, 620 women with suspected/confirmed preeclampsia, aged 18 to 48 years, were included in a prospective, multicenter, observational cohort study. Women had singleton pregnancies and a median pregnancy duration of 34 (range, 20–41) weeks. Complications occurred in 118 women and 248 fetuses. The median duration between admission and delivery was 12 days. To predict prolongation, PlGF showed the highest incremental value ( R 2 =0.72) on top of traditional predictors (gestational age at inclusion, diastolic blood pressure, proteinuria, creatinine, uric acid, alanine transaminase, lactate dehydrogenase, and platelets) compared with R 2 =0.53 for the traditional predictors only. The sFlt-1/PlGF ratio showed the highest value to discriminate women with and without maternal complications (C-index=0.80 versus 0.63 for the traditional predictors only), and to discriminate fetal/neonatal complications (C-index=0.86 versus 0.78 for the traditional predictors only). Applying previously suggested cutoff values for the sFlt-1/PlGF ratio yielded lower incremental values than applying continuous values. In conclusion, sFlt-1 and PlGF are strong and independent predictors for days until delivery along with maternal and fetal/neonatal complications on top of the traditional criteria. Their use as continuous variables (instead of applying cutoff values for different gestational ages) should now be tested in a prospective manner, making use of an algorithm calculating the risk of an individual woman with suspected/confirmed preeclampsia to develop complications.
24
Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan et al. · Journal of Clinical Investigation · 2003 · 4K citations · Full text
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
Richard J. Levine, Chun Sing Lam, Cong Qian et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Harald Zeisler, Elisa Llurba, Frédéric Chantraine et al. · New England Journal of Medicine · 2016 · 1.7K citations · Full text
Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
Sarosh Rana, Camille E. Powe, Saira Salahuddin et al. · Circulation · 2012 · 654 citations · Full text